Joseph Gulfo named executive director of the Rothman Institute at Fairleigh Dickinson University

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

JOSEPH GULFO was named executive director of the Rothman Institute of Innovation and Entrepreneurship at Fairleigh Dickinson University.

The university also launched the Initiative for Patient Centered Innovation, to be led by Gulfo, in collaboration with the School of Pharmacy’s Center for Healthcare Innovation and Technology. Among the programs to be undertaken include the Medical Innovation Impact Index, shadow advisory committee panels, and audits of regulations and guidance documents.

Gulfo is the author of Innovation Breakdown: How the FDA and Wall Street Cripple Medical Advances and a contributor to Inc.com. He has more than 25 years of experience in the pharmaceutical and medical device industries and received the American Business Awards Maverick of the Year Award in 2012. He also teaches graduate courses on strategic innovation management in FDU’s MBA program.

YOU MAY BE INTERESTED IN

 For nearly 30 years, the American Cancer Society’s prostate cancer screening guidelines have advised men to discuss prostate-specific antigen, or PSA, testing with a clinician and weigh potential benefits and harms, rather than treat screening as an unquestioned routine. This “informed decision-making” recommendation was consistent with guidelines from all major professional organizations in the United States, Canada, and Europe. 
For patients with an HPV-related form of throat cancer, treatment is often highly effective, with cure rates as high as 90%, depending on the disease stage. Now, researchers are investigating whether some patients can safely avoid additional treatment while maintaining excellent cancer outcomes.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login